Why technology standards are critical for Quantum-Safe Security

Safeguard Insights

Cybersecurity Medical Devices January 26, 2017

Commentary: Postmarket Management of Cybersecurity in Medical Devices

Over the last 18 months, an alarming number of medical device companies’ challenges with data security have been exposed. In 2015, Hospira’s LifeCare PCA3 and…

Posted by Mike Kijewski

September 15, 2016

Plugging the Holes in Healthcare Data Security

Today, it’s rare to go a week without reading a story in the news about hackers finding and/or exploiting security vulnerabilities in a healthcare setting.…

Posted by Mike Kijewski

May 31, 2012

Q&A: Don Hardison, CEO, Good Start Genetics – “Don’t Take Anything for Granted”

Good Start Genetics is setting the pace for carrier screening. Based on proprietary gene-sequencing technology, Good Start Genetics’ pre-pregnancy test is more accurate and comprehensive,…

Posted by Peter J. Boni

January 9, 2012

Alverix Technology Key to Landmark Flu Test from BD

In the rush of the holidays, you may have missed some recent news from Safeguard Scientifics’ life sciences partner company Alverix. On December 20, 2011,…

Posted by James A. Datin

January 3, 2012

8 Reasons Why We’re Excited about 2012

Recent news and predictions for venture capital have been anything but cheery. With a wobbly economy and uncertainty surrounding government reforms, investors are understandably cautious.…

Posted by James A. Datin

December 16, 2011

Week in Review: VC 2012 Predictions and MediaMath Crowned King of DSPs

In the latest VentureView report, the National Venture Capital Association and Dow Jones & Co. reported that 63 percent of VCs think their portfolio companies…

Posted by John E. Shave III

November 23, 2011

A Focus on Life Sciences

Safeguard Scientifics has a unique and consistent approach to putting capital to work in the life sciences sector. We target capital efficient diagnostic companies that…

Posted by James A. Datin

November 18, 2011

Week in Review: Convergence between Life Sciences and Technology and A Look at New Partner Company Medivo

The convergence between life sciences and technology cannot be ignored. That’s why at Safeguard Scientifics, we consolidated of our life sciences and technology deal teams.…

Posted by John E. Shave III

November 15, 2011

Opportunity in the Migraine Market for NuPathe

Ninety percent of migraine sufferers experience nausea, while 60 percent experience vomiting because of their migraine. As a result, today’s most common migraine treatments that…

Posted by James A. Datin

Content